BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Novillo A, Gaibar M, Romero-Lorca A, Gilsanz MF, Beltrán L, Galán M, Antón B, Malón D, Moreno A, Fernández-Santander A. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World J Gastroenterol 2020; 26(16): 1979-1986 [PMID: 32390708 DOI: 10.3748/wjg.v26.i16.1979]
URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1979.htm
Number Citing Articles
1
Ahmed M. Kabel, Ahmed M. Ashour, Dina A. Ali, Hany H. Arab. The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markersInternational Immunopharmacology 2021; 98: 107830 doi: 10.1016/j.intimp.2021.107830
2
Dong-Sheng Sun, Cang-Hai Guan, Wei-Na Wang, Zeng-Tao Hu, Yu-Qiao Zhao, Xing-Ming Jiang. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axisMicrovascular Research 2021; 134: 104120 doi: 10.1016/j.mvr.2020.104120
3
María Gaibar, Miguel Galán, Alicia Romero-Lorca, Beatriz Antón, Diego Malón, Amalia Moreno, Ana Fernández-Santander, Apolonia Novillo. Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal CancerInternational Journal of Molecular Sciences 2021; 22(3): 1381 doi: 10.3390/ijms22031381
4
Multiple drugsReactions Weekly 2020; 1819(1): 191 doi: 10.1007/s40278-020-82734-y